Kristi is joined by Jake Leach, Chief Technology Officer at Dexcom. Innovation has changed the way we manage chronic disease. For those living with type 1 and type 2 diabetes, a personal innovative ...
Dexcom stock plunged to a four-month low Monday after the Food and Drug Administration issued the diabetes devices maker a warning letter tied to inspections of two facilities in the U.S. The warning ...
Dexcom, Inc. DXCM announced that its Dexcom G6 CGM System would be available for all eligible patients with type 1 and type 2 diabetes in the Canadian province, Manitoba, irrespective of their age. It ...
DexCom (NASDAQ:DXCM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results